VOXZOGO™ (vosoritide) earned U.S. Food and Drug Administration (FDA) approval on November 19, 2021, as the first therapeutic treatment for Achondroplasia. Pediatric orthopaedic surgeon Daniel
...
More than 250,000 people undergo a transurethral procedure each year in the U.S., and up to 10% of those people will experience a postoperative infection
...
Continuous positive airway pressure (CPAP) is the treatment of choice for moderate-to-severe obstructive sleep apnea
...
(2/3/22) First delta, then omicron. The latest Covid variants have spread like wildfire across the
...
An international peer-reviewed medical journal examining global research trends in obstructive sleep apnea (OSA) found
...
(1/28/22) Researchers at the University of Missouri and the University of Minnesota have discovered how
...
The Patient AdvisoR Team iN Orthopaedic ReSearch (PARTNORS) program is now accepting Advisory Team applications
...
A study from the University of Missouri School of Medicine and MU Health Care found
...